참고문헌
- Aoki Y SM, Watanabe M, et al (2000). High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol, 77, 305-9. https://doi.org/10.1006/gyno.2000.5788
- Chatchotikawong U,Ruengkhachorn I, Leelaphatanadit C (2014). Residual disease following conization of women with stage IA-IB1 cervical carcinoma in a high incidence region. Asian Pac J Cancer Prev, 15, 7383-87. https://doi.org/10.7314/APJCP.2014.15.17.7383
- Delgado G BB, Zaino R, Sevin BU, Creasman WT, Major F (1990). Prospective surgical pathological study of diseasefree interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 38, 352-7. https://doi.org/10.1016/0090-8258(90)90072-S
- Horn LC EJ, Hockel M, et al (2005). [Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies]. Pathologe, 26, 266-72. https://doi.org/10.1007/s00292-005-0764-3
- Kamura T ST, Kaku T et al (1999). Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand, 78, 452-7. https://doi.org/10.1080/j.1600-0412.1999.780520.x
- Mamoon N, Hassan U, Mushtaq S, et al (2010). Histopathology of breast carcinoma-an audit of 50 Reports in Rawalpindi, Pakistan. Asian Pac J Cancer Prev, 11, 169-72.
- Nambiar A, Vivek N, Bindu M, et al (2010). Completeness of low anterior resection pathology report: A hospital-based audit with recommendations on improving reporting. Indian J Cancer, 47, 156-9. https://doi.org/10.4103/0019-509X.63010
- Pieterse Q, Kenter G, Gaarenstroom K, et al (2007). The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol, 33, 216-21. https://doi.org/10.1016/j.ejso.2006.09.037
- Prapaporn S KC, Surapan K (2012). Pelvic node removal and disease-free survival in cervical cancer patients treated with radical hysterectomy and pelvic lymphadenectomy. Int J Gynecol Obstet, 116, 43-6. https://doi.org/10.1016/j.ijgo.2011.08.001
- Randall ME FP, Toita T et al (2013) Principles and Practice of gynecologic oncology, Philadelphia, Lipincott Williams and Wilins.
- Samlal RA vdVJ, Ten Kate FJ, Schilthuis MS, Hart AA LF (1997). Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer, 80, 1234-40. https://doi.org/10.1002/(SICI)1097-0142(19971001)80:7<1234::AID-CNCR6>3.0.CO;2-K
- Sethasathien S, Charoenkwan K, Settakorn J, Srisomboon J. (2014). Predicting factors for positive vaginal surgical margin following radical hysterectomy for stage IB1 carcinoma of the cervix. Asian Pac J Cancer Prev, 15, 2211-15. https://doi.org/10.7314/APJCP.2014.15.5.2211
- Sykes P AD, Cohen C, Scurry J, Yeo D (2003). Does the density of lymphatic vascular space invasion affect the prognosis of stage Ib and IIA node negative carcinoma of the cervix? Int J Gynecol Cancer, 13, 313-6. https://doi.org/10.1046/j.1525-1438.2003.13024.x
- Takeda N SN, Takeda M et al (2002). Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand, 81, 1144-51. https://doi.org/10.1034/j.1600-0412.2002.811208.x
- Verleye L VI, Reed N, Ottevanger PB (2009). Quality assurance for radical hysterectomy for cervical cancer: the view of the European organization for research and treatment of cancer?gynecological cancer group (EORTC-GCG). Ann Oncol, 20, 1631-8. https://doi.org/10.1093/annonc/mdp196
- Zreik TG, Chambers JT, Chambers SK (1996). Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstet Gynecol, 87, 741-6. https://doi.org/10.1016/0029-7844(96)00026-9